Giorgio scagliotti biography

Despite all the hurdles we faced inthe IASLC was able to offer several educational meetings and resources, new and enhanced.

Giorgio scagliotti biography: Dr Scagliotti is currently Professor

Despite all of the limitations imposed by mandatory remote working, staff were able to maintain the sense of unity and generated responsive and innovative ideas. Critical times need quick decisions. It was a difficult decision, but we want to ensure a well-established plan for our members. We are almost ready to adopt a new learning management system that will allow increased interaction with our members.

Giorgio scagliotti biography: Giorgio Scagliotti. Professor. Department of Oncology

We do not know when the COVID vaccine will be widely available, and none of us is able to predict the evolution of the current pandemic. It is important to understand the impact of the pandemic on lung cancer-specific studies and to identify measures to mitigate those impacts in order to continue to move the science of lung cancer treatment forward to improve patient outcomes.

Understanding how these vaccine initiatives will likely impact lung cancer clinical trials will be important so researchers can make appropriate adjustments in their ongoing work so as to be complementary to vaccine-related efforts. There is no question that the IASLC is the premiere society in the field of thoracic oncology, the only truly global society that aims to bolster the knowledge base of each individual member through provision of tailored educational offerings.

Additionally, the IASLC aims to foster integration of regional and international advocacy groups in with the scientific lung cancer community to amplify the concerns and opinions of patients in the research cycle. The IASLC believes that diverse gender, race, and ethnicity, along with varied skills, perspectives, and experiences, contributes to a balanced and effective organization, which truly resonates with me as a vitally important component of a member-driven global organization.

Together we will make the difference. Together we will defeat lung cancer and other thoracic malignancies.

Giorgio scagliotti biography: Biography. Giorgio Vittorio Scagliotti

Share 0. CAR T-cell Therapy. Disparities in Cancer Care. Global Oncology. Gynecologic Oncology Gynecologic Oncology.

Giorgio scagliotti biography: Bio Dr Scagliotti is currently

Lung Cancer. Oncology Business Management. Pediatric Oncology. Supportive Care. Scagliotti, MD, PhD. Latest Updated Articles. Published: December 24th Updated: January 28th Published: December 17th Updated: January 16th Real-world comparison of the efficacy and safety of atezolizumab versus durvalumab in extensive-stage small cell lung cancer.

Published: January 6th Updated: January 8th Published: December 3rd Updated: December 6th Published: October 30th Updated: November 7th Published: October 18th Updated: October 21st